Rgls stock price target
RGLS Regulus Therapeutics Inc. Stock Quote Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. RGLS - Research and Analysis for REGULUS THERAPEUTICS INC ... In-depth view of key statistics and finances for REGULUS THERAPEUTICS INC. (RGLS) on MSN Money.
See Regulus price target based on 3 analysts offering 12 month price targets for Regulus in the last 3 months. The average price target is $1.50 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 212.50% increase from the last price of $0.48.
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs RGLS Regulus Therapeutics Inc. Stock Quote Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. RGLS - Research and Analysis for REGULUS THERAPEUTICS INC ... In-depth view of key statistics and finances for REGULUS THERAPEUTICS INC. (RGLS) on MSN Money. Ideas and Forecasts on REGULUS THERAPEUTICS INC — …
by multiplying the current stock price by the number of shares outstanding. and developing drugs that target microRNAs, called microRNA therapeutics.
RGLS Price Target - ETF Channel
Nov 06, 2019 · 3 Wall Street analysts have issued ratings and price targets for Regulus Therapeutics in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 215.06%. The high price target for RGLS is …
Possible pullback play here for a aggressive speculative setup. * Trade Criteria * Date First Found- January 10, 2018 Pattern/Why- Long from support; Speculative Pullback play Entry Target Criteria- Pull back to $1.10; Speculative entry at current price Exit Target Criteria- Momentum Stop Loss Criteria- N/A Special Note- Lots of insider buying Please check Time and Sales - Intraday Stock Last Price History for ... NASDAQ Last Sale (NLS) Intraday Stock History Report: Time and sales data for Regulus Therapeutics Inc. (RGLS) Regulus Therapeutics Inc. (RGLS) stock price, quote ... Regulus (RGLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Simply Wall St. If you're interested in Regulus Therapeutics Inc. (NASDAQ:RGLS), then you might want to consider its beta (a REGULUS THERAPEUTICS INC : RGLS Stock Price | MarketScreener
Based on analysts offering 12 month price targets for RGLS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your
Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically Detailed price information for Regulus Therapeutics (RGLS-Q) from The Globe and Mail including charting and trades. focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. Stock Reports +. Please note that any opinions, estimates or forecasts regarding Regulus Therapeutics Inc.'s performance made by these analysts are theirs alone and do not Mar 12, 2020 Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a by multiplying the current stock price by the number of shares outstanding. and developing drugs that target microRNAs, called microRNA therapeutics. Get detailed information on REGULUS THERAPEUTICS INC (RGLS.NQ) including stock quotes, financial news, historical charts, company background, Regulus Therapeutics Inc. (RGLS) flow (DCF) valuation over 15 years showing the resulting Target Share Price. Preferred Stock and Other Adjustments.
Nov 05, 2019 · RGLS, Regulus Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Stock Comparison: Compare Regulus Therapeutics Inc. (RGLS ... Online Stock Comparison - Compare Regulus Therapeutics Inc. (RGLS) to four other stocks with NASDAQ.com's stock comparison tool. RGLS - Regulus Therapeutics Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Zacks: Analysts Anticipate Regulus Therapeutics Inc ... Wall Street analysts forecast that Regulus Therapeutics Inc (NASDAQ:RGLS) will report $5.01 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Regulus Therapeutics’ earnings, with the highest sales estimate coming in at $10.00 million and the lowest estimate coming in at $20,000.00.